The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
The use of natural and synthetic phospholipids as pharmaceutical excipients
Open accessAbstract
In pharmaceutical formulations, phospholipids obtained from plant or animal sources and synthetic phospholipids are used. Natural phospholipids are purified from, e.g., soybeans or egg yolk using non‐toxic solvent extraction and chromatographic procedures with low consumption of energy and minimum possible waste. Because of the use of validated purification procedures and sourcing of raw materials with consistent quality, the resulting products differing in phosphatidylcholine content possess an excellent batch to batch reproducibility with respect to phospholipid and fatty acid composition. The natural phospholipids are described in pharmacopeias and relevant regulatory guidance documentation of the Food and Drug Administration (FDA) and European Medicines Agency (EMA). Synthetic phospholipids with specific polar head group, fatty acid composition can be manufactured using various synthesis routes. Synthetic phospholipids with the natural stereochemical configuration are preferably synthesized from glycerophosphocholine (GPC), which is obtained from natural phospholipids, using acylation and enzyme catalyzed reactions. Synthetic phospholipids play compared to natural phospholipid (including hydrogenated phospholipids), as derived from the number of drug products containing synthetic phospholipids, a minor role. Only in a few pharmaceutical products synthetic phospholipids are used. Natural phospholipids are used in oral, dermal, and parenteral products including liposomes. Natural phospholipids instead of synthetic phospholipids should be selected as phospholipid excipients for formulation development, whenever possible, because natural phospholipids are derived from renewable sources and produced with more ecologically friendly processes and are available in larger scale at relatively low costs compared to synthetic phospholipids. Practical applications: For selection of phospholipid excipients for pharmaceutical formulations, natural phospholipids are preferred compared to synthetic phospholipids because they are available at large scale with reproducible quality at lower costs of goods. They are well accepted by regulatory authorities and are produced using less chemicals and solvents at higher yields. In order to avoid scale up problems during pharmaceutical development and production, natural phospholipid excipients instead of synthetic phospholipids should be selected whenever possible. For selection of phospholipid excipients for pharmaceutical formulations, natural phospholipids are preferred compared to synthetic phospholipids because they are available at large scale with reproducible quality at lower costs of goods. They are well accepted by regulatory authorities and are produced using less chemicals and solvents at higher yields. In order to avoid scale up problems during pharmaceutical development and production, natural phospholipid excipients instead of synthetic phospholipids should be selected whenever possible.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kirk‐Othmer Encyclopedia of Chemical Technology
Pfenning, A. (1995) · Chemie Ingenieur Technik · doi:10.1002/cite.330670827 · Cited by 1,427
Haran, G., Cohen, R., Bar, L. K., & Barenholz, Y. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90105-9 · Cited by 934
Role of nanotechnology in targeted drug delivery and imaging: a concise review
Koo, O. M., Rubinstein, I., & Onyuksel, H. (2005) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2005.06.004 · Cited by 718
(2018) · CRC Press eBooks · doi:10.1201/9780203743577 · Cited by 587
Bovine surfactant therapy for patients with acute respiratory distress syndrome.
Gregory, T. J., Steinberg, K. P., Spragg, R., Gadek, J. E., Hyers, T. M., Longmore, W. J., Moxley, M. A., Cai, G. Z., Hite, R. D., Smith, R. M., et al. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.4.9105072 · Cited by 371
Exposure of platelet membrane phosphatidylserine regulates blood coagulation
Lentz, B. R. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00025-0 · Cited by 371
Nanoemulsion: A pharmaceutical review
Shah, P., Bhalodia, D., & Shelat, P. (2010) · Systematic Reviews in Pharmacy · doi:10.4103/0975-8453.59509 · Cited by 368
Senior, J., & Gregoriadis, G. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90455-6 · Cited by 355
Phospholipids and Lipid-Based Formulations in Oral Drug Delivery
Fricker, G., Kromp, T., Wendel, A., Blume, A., Zirkel, J., Rebmann, H., Setzer, C., Quinkert, R.-O., Martin, F., & Müller-Goymann, C. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0130-x · Cited by 326
Self-citationDevelopment of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphere™ Technology
Geller, D. E., Weers, J., & Heuerding, S. (2011) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2010.0855 · Cited by 308
Bornscheuer, U. T. (2018) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-030117-012336 · Cited by 199
A method for the synthesis of isomerically pure saturated mixed-chain phosphatidylcholines
Mason, J. T., Broccoli, A. V., & Huang, C.-H. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90049-x · Cited by 164
Gambling, D. R., Hughes, T., Martin, G., Horton, W., & Manvelian, G. Z. (2005) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000145009.03574.78 · Cited by 148
Phospholipids as Functional Constituents of Biomembranes
Eibl, H. (1984) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198402573 · Cited by 138
Crans, D. C., & Whitesides, G. M. (1985) · Journal of the American Chemical Society · doi:10.1021/ja00310a045 · Cited by 103
CD14-dependent clearance of apoptotic cells by human macrophages: the role of phosphatidylserine
Devitt, A., Pierce, S., Oldreive, C., Shingler, W. H., & Gregory, C. D. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401168 · Cited by 99
MacDonald, R. C., Rakhmanova, V. A., Choi, K. L., Rosenzweig, H. S., & Lahiri, M. K. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js990006q · Cited by 82
Vertzoni, M., Markopoulos, C., Symillides, M., et al. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200479f · Cited by 71
Role of Phosphatidyl-Serine in Bone Repair and Its Technological Exploitation
Merolli, A., & Santin, M. (2009) · Molecules · doi:10.3390/molecules14125367 · Cited by 57
Phospholipids: "Biochemical, Pharmaceutical, And Analytical Considerations"
Hanin, I., & Pepeu, G. (2013) · Medical Entomology and Zoology · Cited by 36
Role of phospholipids in the oral and parenteral delivery of poorly water soluble drugs
van Hoogevest, P., Liu, X., Fahr, A., & Leigh, M. L. S. (2011) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(11)50001-2 · Cited by 28
Phospholipid synthesis: effects of solvents and catalysts on acylation
Mangroo, D., & Gerber, G. E. (1988) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(88)90137-5 · Cited by 17
Cada, D. J., Cong, J., & Baker, D. E. (2015) · Cited by 4
Cited by
Liposomes: Structure, composition, types, and clinical applications
Nsairat, H., Khater, D., Sayed, U., Odeh, F., Al Bawab, A., & Alshaer, W. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09394 · Cited by 1,561
Transfersomes: A Promising Nanoencapsulation Technique for Transdermal Drug Delivery
Opatha, S. A. T., Titapiwatanakun, V., & Chutoprapat, R. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090855 · Cited by 537
Phospholipids of Animal and Marine Origin: Structure, Function, and Anti-Inflammatory Properties
Lordan, R., Tsoupras, A., & Zabetakis, I. (2017) · Molecules · doi:10.3390/molecules22111964 · Cited by 297
Fernández-García, R., Lalatsa, A., Statts, L., Bolás-Fernández, F., Ballesteros, M. P., & Serrano, D. R. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118817 · Cited by 289
Jo, K., Cho, J. M., Lee, H., Kim, E. K., Kim, H. C., Kim, H., & Lee, J. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics11010001 · Cited by 266
Metadata
- Authors
- van Hoogevest, P., & Wendel, A.
- Venue
- European Journal of Lipid Science and Technology
- Publisher
- Wiley
- Published
- 2014-08-25
- Volume
- 116
- Issue
- 9
- Pages
- 1088-1107
- ISSN
- 1438-7697 (ISSN-L)
- 1438-9312
- OpenAlex
- W1484126258
- Cited by
- 418
- References
- 23
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.